Firms

Adeline Arts and Science

116 High Holborn, Third Floor, London WC1V 6RD, United Kingdom

adeline.co.uk

Adeline is the London family office operating adeline.co.uk and publicly identifying its operator as Adeline Arts & Science Ltd. The exact UK legal company is ADELINE ARTS AND SCIENCE LTD, Companies House13110623, active and incorporated January4,2021, with registered office116HighHolborn,ThirdFloor,LondonWC1V6RD, matching the own contact address. The incorporation year is not an invented earlier investment-platform founding date. The own website explicitly says it is not FCA-authorised or regulated, offers no investment advisory services and does not solicit investment from the general public. It is kept distinct from unrelated Adeline-named businesses and from third-party investment firms listed in its educational investor directory. That directory is not Adeline’s own team, managed-fund list or co-investor graph. The family office backs pre-seed through SeriesA technology companies and follows on, with a published average cheque of GBP150K and a five-to-ten-year investment horizon. These are strategy parameters, not amounts assigned to particular portfolio companies. Its mandate spans frontier technology, infrastructure, AI, deep science, climate and health, alongside film, publishing and scientific-research support. The no-fees/no-equity Founders’ Floor provides workspace, community and workshops; membership is not an equity subscription. No external-LP fund, closed fundraising cash, AUM or government programme budget is established. Own calls itself a family office; loose uses of “fund” do not prove a separate legal fund vehicle. The complete own published team comprises Des Tan (Founder & Director), Jaysri “Jay” Thangam Ananthpadmanabhan (Investment Principal), Liz Ann Bennett (VP of Operations and Strategy), Theo Brainin (VP of Growth and Marketing), Meerab Baig (Platform Associate), Andrea Puma (Facilities Manager) and Jason Ward (Script and Production Associate). All seven have individually identified original authentic portraits and meaningful own-source career biographies. Des’s biography covers Oxford mathematical biology, Australian governmental strategy, and analytics/digital health. The statutory Companies House director is filed as Derek Tan, while the own public team uses Des Tan; the possible name bridge is not independently established, so no legal-name alias, birth date or registry appointment day is silently attached to the public person. Public roles and appointment dates remain source-qualified. Own “portfolio and partners” includes AI investment-workflow company Capsa AI, AI manufacturing company CloudNC, secure enterprise AI-agent platform Credal, AI ophthalmic-genetics company Eye2Gene, infection-prevention AI platform NEX Health Intelligence, sodium-battery innovator TaiSan, stellarator developer Proxima Fusion, agentic-payments platform Ralio and critical-pharmaceutical infrastructure company Genhtis. It also includes universities, charities, research institutes, scholarships, arts organisations and third-party funds; this heterogeneous relationship category is not assumed to consist entirely of equity checks. Stage tags are descriptive page classifications, not proof of an exact closed round date or subscriber allocation. A total of29 own directory affiliations are queued for scoped identity and transaction audits, with relevant AI/deeptech companies prioritised. Eye2Gene’s own current supporter directory links exactly to Adeline, and Adeline’s own portfolio names Eye2Gene as an AI/health Seed-stage company. Together these establish a public portfolio/support relationship. They do not identify the buyer of Eye2Gene’s unnamed statutory share allotments, a particular subscribed security, cash ticket, funding date or specific seed financing event. The issuer-profile owner records exactly one source-qualified undated relationship with unknown amount; no duplicate personal founder check, programme buyer or guessedGBP150K ticket is inferred. Other issuer actual cash events require separate primary financing proof before graph additions.

Founded: 2021
Type: Venture capital